The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm?
Open accessAbstract
Summary: In January 2008, the U.S. Food and Drug Administration (FDA) issued an alert about an increased risk for suicidality in 199 clinical trials of 11 antiepileptic drugs (AEDs) for three different indications, including epilepsy. An advisory panel voted against a black‐box warning on AED labels, and the FDA has accepted this recommendation. We discuss three potential problems with the alert. First, adverse event data were used rather than systematically collected data. Second, the 11 drugs grouped together as a single class of AEDs have different mechanisms of action and very different relative risks, many of which were not statistically significant and some of which were smaller than one. These facts suggest that they should not be grouped as a class. Third, the risk of adverse effects from uncontrolled seizures almost certainly outweighs the small risk of suicidality. We place our comments in the context of a review of the literature on suicidality and depression in epilepsy and the sparse literature on AEDs and suicidality. We recommend that all patients with epilepsy be routinely evaluated for depression, anxiety, and suicidality, and that future clinical trials include validated instruments to systematically assess these conditions to determine whether the possible signal observed by the FDA is real.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients
Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996) · Journal of Personality Assessment · doi:10.1207/s15327752jpa6703_13 · Cited by 5,965
Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection
Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O., & Löwe, B. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00004 · Cited by 4,741
Psychiatric comorbidity in epilepsy: a population-based analysis
Tellez‐Zenteno, J. F., Patten, S. B., Jetté, N., Williams, J., & Wiebe, S. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01222.x · Cited by 1,113
Depression and suicide attempt as risk factors for incident unprovoked seizures
Hesdorffer, D. C., Hauser, W. A., Olafsson, E., Ludvigsson, P., & Kjartansson, O. (2006) · Annals of Neurology · doi:10.1002/ana.20685 · Cited by 524
Self-citation
Cited by
Devinsky, O., Vezzani, A., O'Brien, T. J., Jette, N., Scheffer, I. E., de Curtis, M., & Perucca, P. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.24 · Cited by 959
Epilepsy, suicidality, and psychiatric disorders: a bidirectional association
Hesdorffer, D. C., Ishihara, L., Mynepalli, L., Webb, D. J., Weil, J., & Hauser, W. A. (2012) · Annals of Neurology · doi:10.1002/ana.23601 · Cited by 610
Self-citationManagement of psychiatric and neurological comorbidities in epilepsy
Kanner, A. M. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.243 · Cited by 451
Self-citationAntidepressants for people with epilepsy and depression
Maguire, M. J., Marson, A. G., & Nevitt, S. J. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010682.pub3 · Cited by 57
Non-psychotropic medication and risk of suicide or attempted suicide: a systematic review
Gorton, H. C., Webb, R. T., Kapur, N., & Ashcroft, D. M. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-009074 · Cited by 31
Metadata
- Authors
- Hesdorffer, D. C., & Kanner, A. M.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2009-05
- Volume
- 50
- Issue
- 5
- Pages
- 978-986
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W2007339452
- Cited by
- 185
- References
- 4
- FWCI
- 12.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm? https://app.cochat.ai/papers/10.1111/j.1528-1167.2009.02012.x
- The paper
- Hesdorffer, D. C., & Kanner, A. M. (2009). The FDA alert on suicidality and antiepileptic drugs: Fire or false alarm? Epilepsia. https://doi.org/10.1111/j.1528-1167.2009.02012.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.